Tenofovir Alafenamide Tablet

Product Description

Tenofovir alafenamide (TAF) is an antiretroviral medication used in the treatment of HIV infection. It belongs to the class of drugs known as nucleotide reverse transcriptase inhibitors (NRTIs). 

Tenofovir alafenamide is a prodrug of tenofovir, meaning it is metabolized in the body into its active form, tenofovir. Tenofovir works by inhibiting the action of reverse transcriptase, an enzyme that HIV needs to replicate. By interfering with HIV replication, tenofovir helps to reduce the viral load in the body and slow down the progression of HIV infection.

Tenofovir alafenamide is known for its improved safety profile compared to the older formulation of tenofovir, tenofovir disoproxil fumarate (TDF). It has been associated with lower risks of kidney toxicity and bone density loss.

The dosage of tenofovir alafenamide tablets can vary depending on the specific treatment regimen prescribed by a healthcare provider. Typically, tenofovir alafenamide is used in combination with other antiretroviral medications as part of a comprehensive HIV treatment regimen known as antiretroviral therapy (ART).

Common side effects of tenofovir alafenamide may include nausea, diarrhea, headache, fatigue, and changes in kidney function. It's important for individuals taking tenofovir alafenamide to adhere to their prescribed dosage regimen consistently and to report any unusual or severe symptoms to their healthcare provider promptly.

As with any medication, tenofovir alafenamide tablets can interact with other drugs, so it's important for patients to inform their healthcare provider about all medications, supplements, and herbal products they are taking before starting tenofovir alafenamide therapy.

Overall, tenofovir alafenamide is an important component of HIV treatment and has been shown to be effective in helping people with HIV manage their condition and improve their quality of life.

Exceptional Antiviral Efficacy

Tenofovir Alafenamide 25 mg targets viral replication in both HIV-1 and chronic Hepatitis B, offering a potent defense in the management of these conditions. Its advanced formulation enables increased efficacy at a lower dose, with daily oral administration simplifying treatment. Consult your healthcare provider to determine if it fits your therapeutic regimen.


Enhanced Safety Profile

The tablet's improved renal and bone safety sets it apart from previous tenofovir formulations. Its higher intracellular concentration allows effective virus control while reducing the risk of kidney or bone complications. This safety makes it an appealing choice, especially for long-term management of HIV and Hepatitis B.


Convenient Once-Daily Dosing

With once-daily administration, Tenofovir Alafenamide 25 mg promotes adherence and simplifies antiviral therapy. Its film-coated tablet format is easy to swallow and comes in flexible packaging options-either in bottles or blister packs-catering to both clinical and personal use cases.